Physician
Hematology
Dr. Thomas A. Marsland, MD
|
|
Give Review
Thomas Marsland is an expert in the field of Hematology. He researched medicine at Temple University School of Medicine. He has 3 awards "Fellow (FASCO)", "CMS Meaningful Use Stage 1 Certification" and "Top Doctors: Florida". Thomas Marsland is also a published MD. He has 15 publication published. The most recent publication is: Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience. Thomas Marsland is registered with Medicare and accepts Medicare payments.
Publications
- Lung cancer screening: a new era.
- Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer.
- Reducing cancer costs and improving quality through collaboration with payers: a proposal from the Florida society of clinical oncology.
- American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.
- Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.
- Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance...
- Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.
- Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
- Pegylated liposomal doxorubicin as single-agent treatment of low-grade non-Hodgkin's lymphoma: a phase II multicenter study.
- A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer.
- Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results.
- Breast Cancer Screening Project in Northeast Florida.
- Parallel game-tree search.
- Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience.
Schools
Temple University Philadelphia Pa
Tufts Boston MA
University of Massachussetts Worcester MA
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- Fellow (FASCO)
- CMS Meaningful Use Stage 1 Certification
- Top Doctors: Florida
Education
-
University of Massachusetts -
Tufts Medical Center -
Temple University Hospital -
Temple University School of Medicine
Drug Facts
| NPI NUMBER | 1477558716 | |
| NPPES Provider LastName | MARSLAND | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 320735113 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 728.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 82.0 | |
| Percent Opioid Claims | 11.26 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477558716 |
| Last Name Of The Provider | MARSLAND |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Laura E. Finn, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sahana R. Kalmadi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth H. Goldstein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas G. Gaddis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Abhisek Swaika, MB BS |
|
|
Bridget E. Freeman, MB
This Doctor is OpenDoctor Recommended.
|